CD34 Nu-Signals
Commercial- Indications
- Aging, Cancer prevention, Immune system enhancement
Company intelligence / Profile preview
Beauty-Stem Biomedical markets CD34 Nu-Signals®, an FDA-approved, laboratory-proven oral supplement designed to increase endogenous CD34 stem cells. The product is claimed to enhance immunity, promote tissue repair, and support anti-aging. Clinical data cited by the company suggest benefits in immune function and regenerative capacity, but these are positioned as wellness claims rather than formal drug trial results. The technology uses micro-liposome encapsulation for targeted delivery.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beauty-Stem Biomedical.